Kif15-IN-2 structure
|
Common Name | Kif15-IN-2 | ||
---|---|---|---|---|
CAS Number | 672926-33-9 | Molecular Weight | 440.476 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C20H20N6O4S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Kif15-IN-2Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15, and is used for the research of cellular proliferative diseases. |
Name | Kif15-IN-2 |
---|---|
Synonym | More Synonyms |
Description | Kif15-IN-2 is an inhibitor of the mitotic kinesin Kif15, and is used for the research of cellular proliferative diseases. |
---|---|
Related Catalog | |
Target |
KIF15 |
In Vitro | Kif15-IN-2 (Compound 14) is an inhibitor of the mitotic kinesin Hs Kif15, with the potential activities against cellular proliferative diseases such as cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation[1]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C20H20N6O4S |
Molecular Weight | 440.476 |
Exact Mass | 440.126678 |
LogP | 1.57 |
Index of Refraction | 1.639 |
Storage condition | 2-8℃ |
3(2H)-Quinazolineacetamide, 1,4-dihydro-α-(1-methylethyl)-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-2-thiazolyl]-2,4-dioxo-, (αS)- |
(2S)-2-(2,4-Dioxo-1,4-dihydro-3(2H)-quinazolinyl)-3-methyl-N-[4-methyl-5-(5-methyl-1,3,4-oxadiazol-2-yl)-1,3-thiazol-2-yl]butanamide |